Pharmacokinetics, converting enzyme inhibition and peripheral arterial hemodynamics of ramipril in healthy volunteers
- 24 April 1987
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 59 (10) , D38-D44
- https://doi.org/10.1016/0002-9149(87)90051-8
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The effect of the converting enzyme inhibitor HOE 498 on the renin angiotensin system of normal volunteersNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1985
- Effects of Acute and Chronic Angiotensin-Converting Enzyme Inhibition on Large Arteries in Human HypertensionJournal of Cardiovascular Pharmacology, 1985
- Nicardipine: pharmacokinetics and effects on carotid and brachial blood flows in normal volunteers.British Journal of Clinical Pharmacology, 1984
- Captopril-induced changes in large arteries in essential hypertensionThe American Journal of Medicine, 1984
- Pharmacokinetics and pharmacodynamics of a novel orally active angiotensin converting enzyme inhibitor (HOE 498) in healthy subjectsEuropean Journal of Clinical Pharmacology, 1984
- Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.Heart, 1983
- Pulsed Doppler: diameter, blood flow velocity and volumic flow of the brachial artery in sustained essential hypertension.Circulation, 1981
- Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.Heart, 1980
- CAPTOPRIL IN THE TREATMENT OF CLINICAL HYPERTENSION AND CARDIAC FAILUREThe Lancet, 1979
- Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive PatientsAnnals of Internal Medicine, 1979